These findings are consistent with the study by Rastogi et al., where the use of PLCL/Fg dressings alleviated diabetes-induced wound inflammation by inhibiting inflammatory signaling pathways such as IL-17 and TNF, promoting the transition of macrophages from M1 to M2 phenotype, thereby accelerating wound healing (22). Here, IL17A is linked to diabetes mellitus.